Disseminated molluscum contagiosum in a patient with chronic lymphocytic leukaemia after alemtuzumab.
Pitini
Vincenzo
V
Department of Oncology, University of Messina, Messina, Italy. pitini@ciaoweb.it
Arrigo
Carmela
C
Barresi
Gaetano
G
D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D008976:Molluscum Contagiosum / Q000150:complications* / Q000276:immunology; D009894:Opportunistic Infections / Q000150:complications* / Q000276:immunology; D012867:Skin / Q000469:parasitology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab